Is there a place for combination medical therapy?

Current Opinion in Urology

Volumn 11, Issue 1, 2001, Pages 17-25

  Roehrborn, C G ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; DUTASTERIDE; FINASTERIDE; PHENOXYBENZAMINE; STEROID 5ALPHA REDUCTASE INHIBITOR; TAMSULOSIN; TERAZOSIN;

ALPHA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; ENZYME INHIBITION; HUMAN; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCORING SYSTEM; URETHRA DISEASE;

COMBINED MODALITY THERAPY; CONTROLLED CLINICAL TRIALS; HUMANS; MALE; PLACEBOS; PROSTATIC HYPERPLASIA; URINATION DISORDERS;

EID: 0035155815     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200101000-00003     Document Type: Review

References (14)

1. Benign prostatic hyperplasia: Diagnosis and treatment. Agency for Health Care Policy and Research
2. Recommendations of the International Scientific Committee: The evaluation and treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction
3. The effect of finasteride in men with benign prostatic hyperplasia
4. A trial of the use of finasteride and terazosin in patients with benign prostatic hyperplasia
5. Peak flow and IPSS changes in patients treated with a combination of finasteride and terazosin after withdrawing terazosin
6. Combination of proscar and terazosin in BPH patients with severe obstructive symptoms and large prostate volume
7. Comparative study of therapeutic effect of dibenyline, finasteride, and combination drugs for symptomatic benign prostatic hyperplasia
8. Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia
9. Combination medical therapy for symptomatic benign prostatic hyperplasia
10. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia
11. The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response
12. Results of PREDICT (Prospective Randomized European Doxazosin and Combination Trial) study of medical therapy for BPH
13. Categorical flow rate changes in men with LUTS and BPH treated with doxazosin, finasteride, or combination versus placebo
14. A double-blind comparison of doxazosin and finasteride in symptomatic benign prostatic hyperplasia: A multinational European trial